Floatz logo

Nano-Crystalline Megestrol Acetate Suspension

The Pre-cachexia or Cachexia Patients Who Have Not Received Systemic Treatment and Are Not Eligible for Curative Therapy

Changchun GeneScience Pharmaceutical Co., Ltd.Phase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the The Pre-cachexia or Cachexia Patients Who Have Not Received Systemic Treatment and Are Not Eligible for Curative Therapy cohort.

Asset / SponsorPhaseRating
MEGESTROL ACETATE IMPURITY B
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3B

Same molecule, other indications

Nano-Crystalline Megestrol Acetate Suspension is also rated in:

Untreated With Systemic TherapyDormant
B
Indicative ·
60 / 100
View asset →
small cell lung carcinomaDormant
B
Indicative ·
60 / 100
View asset →
Cancer-related Fatigue， Gastric Cancer，Colorectal Cancer，Nano-crystalline Megestrol Acetate，Megestrol Acetate，First-line TreatmentDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →